Herophilus

Approach

Herophilus is focused on curing complex brain diseases with a novel approach that combines advanced organoid science, robotic automation, and advanced machine learning to enable discovery of drug compounds with significantly increased confidence of clinical efficacy.

Our work with Herophilus began with the hiring announcement of their new Chief Scientific Officer, a renowned “drug hunter” with decades of leadership experience in drug development.

After a successful announcement, we then continued to create the company’s corporate positioning, craft tailored messaging for key audiences, and drive brand awareness as they continued to pursue deep advances in advanced neuroscience, robotics, and machine learning.

Impact

To date, our work with Herophilus has focused primarily on utilizing narrative-driven stories to highlight the company’s innovative science and technology as well as the executives’ roles as leaders in drug discovery, automation, and machine learning.

Herophilus’s innovative approach to neurotherapeutics, the significance of their research, and its potential impact on the future of complex brain diseases has been featured on BioIT World, BioWorld, and Technology Networks.

Our work to publicize key additions to the Herophilus team has engaged 82.6k readers online across leading publications such as Endpoints and Forbes, as well as relevant newsletters like Fierce’s Chutes and Ladders.

We continue to focus on advancing executive thought leadership with ongoing speaking and awards programs, which have resulted in Herophilus being named a quarterfinalist for the UCSF Health Awards, as well as key features on leading podcasts such as The Bio Report with Daniel Levine and SynBioBeta Built With Biology.

We continue to support social and content channels with custom creative assets to educate audiences, engage with key audiences, and advance hiring efforts.